Tsh Biopharmoration (Taiwan) Insiders

8432 Stock  TWD 61.20  0.20  0.33%   
Tsh Biopharmoration employs about 80 people. The company is managed by 5 executives with a total tenure of roughly 8 years, averaging almost 1.0 years of service per executive, having 16.0 employees per reported executive. Recap of Tsh Biopharmoration's management performance can provide insight into the venture performance.
ChenJu Kan  Insider
Mang Admin
JianRong Huang  Insider
Sales Director
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in tsh biopharmoration. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Tsh Biopharmoration Management Team Effectiveness

The company has return on total asset (ROA) of 0.0387 % which means that it generated a profit of $0.0387 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0635 %, meaning that it generated $0.0635 on every $100 dollars invested by stockholders. Tsh Biopharmoration's management efficiency ratios could be used to measure how well Tsh Biopharmoration manages its routine affairs as well as how well it operates its assets and liabilities.

Tsh Biopharmoration Workforce Comparison

tsh biopharmoration is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers - Major industry is presently estimated at about 669. Tsh Biopharmoration retains roughly 80.0 in number of employees claiming about 12% of equities under Drug Manufacturers - Major industry.
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16.

tsh biopharmoration Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. tsh biopharmoration Price Series Summation is a cross summation of Tsh Biopharmoration price series and its benchmark/peer.

Tsh Biopharmoration Notable Stakeholders

A Tsh Biopharmoration stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Tsh Biopharmoration often face trade-offs trying to please all of them. Tsh Biopharmoration's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Tsh Biopharmoration's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Tsh Biopharmoration Management Performance

The success or failure of an entity such as tsh biopharmoration often depends on how effective the management is. Tsh Biopharmoration management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Tsh management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Tsh management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
TSH Biopharm Corporation Limited develops, manufactures, and markets drugs for various chronic diseases in Taiwan and China. TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited. TSH BIOPHARM is traded on Taiwan OTC Exchange in Taiwan.
Please note, the imprecision that can be found in Tsh Biopharmoration's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of tsh biopharmoration. Check Tsh Biopharmoration's Beneish M Score to see the likelihood of Tsh Biopharmoration's management manipulating its earnings.

Tsh Biopharmoration Workforce Analysis

Traditionally, organizations such as Tsh Biopharmoration use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Tsh Biopharmoration within its industry.

Tsh Biopharmoration Manpower Efficiency

Return on Tsh Biopharmoration Manpower

Revenue Per Employee5.2M
Revenue Per Executive82.7M
Net Income Per Employee588.9K
Net Income Per Executive9.4M

Additional Tools for Tsh Stock Analysis

When running Tsh Biopharmoration's price analysis, check to measure Tsh Biopharmoration's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tsh Biopharmoration is operating at the current time. Most of Tsh Biopharmoration's value examination focuses on studying past and present price action to predict the probability of Tsh Biopharmoration's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tsh Biopharmoration's price. Additionally, you may evaluate how the addition of Tsh Biopharmoration to your portfolios can decrease your overall portfolio volatility.